Skip to main content
Erschienen in: Cancer Immunology, Immunotherapy 8/2014

01.08.2014 | Original Article

Altered chemokine production and accumulation of regulatory T cells in intestinal adenomas of APCMin/+ mice

verfasst von: Paulina Akeus, Veronica Langenes, Astrid von Mentzer, Ulf Yrlid, Åsa Sjöling, Pushpa Saksena, Sukanya Raghavan, Marianne Quiding-Järbrink

Erschienen in: Cancer Immunology, Immunotherapy | Ausgabe 8/2014

Einloggen, um Zugang zu erhalten

Abstract

Tumor progression in the colon moves from aberrant crypt foci to adenomatous polyps to invasive carcinomas. The composition of the tumor-infiltrating leukocyte population affects the ability of the immune system to fight the tumor. T cell infiltration into colorectal adenocarcinomas, particularly T helper 1 (Th1) type T cells as well as increased regulatory T cell (Treg) frequencies, is correlated with improved prognosis. However, whether Th1 cells and Tregs are already present at the adenoma stage is not known. In this study, the APCMin/+ mouse model of intestinal adenomatous polyposis was used to investigate tumor-associated lymphocyte subsets and the mechanisms of their accumulation into gastrointestinal adenomas. Compared to unaffected tissue, adenomas accumulated CD4+FoxP3+ putative Treg in parallel with lower frequencies of conventional T cells and B cells. The accumulation of Treg was also observed in human adenomatous polyps. Despite high Treg numbers, the function of conventional T cells present in the APCMin/+ adenomas was not different from those in the unaffected tissue. Adenomas displayed an altered chemokine balance, with higher CCL17 and lower CXCL11 and CCL25 expression than in the unaffected tissue. In parallel, CXCR3+ Tregs were largely absent from adenomas. The data indicate that already in early stages of tumor development, the balance of lymphocyte-recruiting chemokines is altered possibly contributing to the observed shift toward higher frequencies of Treg.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
7.
Zurück zum Zitat Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, Berger A, Bruneval P, Fridman WH, Pages F, Galon J (2011) Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer. Cancer Res 71:1263–1271. doi:10.1158/0008-5472.CAN-10-2907 PubMedCrossRef Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, Berger A, Bruneval P, Fridman WH, Pages F, Galon J (2011) Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer. Cancer Res 71:1263–1271. doi:10.​1158/​0008-5472.​CAN-10-2907 PubMedCrossRef
8.
Zurück zum Zitat Enarsson K, Lundin BS, Johnsson E, Brezicka T, Quiding-Järbrink M (2007) CD4+CD25 high regulatory T cells reduce T cell transendothelial migration in cancer patients. Eur J Immunol 37:282–291. doi:10.1002/eji.200636183 PubMedCrossRef Enarsson K, Lundin BS, Johnsson E, Brezicka T, Quiding-Järbrink M (2007) CD4+CD25 high regulatory T cells reduce T cell transendothelial migration in cancer patients. Eur J Immunol 37:282–291. doi:10.​1002/​eji.​200636183 PubMedCrossRef
12.
Zurück zum Zitat Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942–949. doi:10.1038/nm1093 PubMedCrossRef Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942–949. doi:10.​1038/​nm1093 PubMedCrossRef
13.
Zurück zum Zitat Hiraoka N, Onozato K, Kosuge T, Hirohashi S (2006) Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 12:5423–5434. doi:10.1158/1078-0432.CCR-06-0369 PubMedCrossRef Hiraoka N, Onozato K, Kosuge T, Hirohashi S (2006) Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 12:5423–5434. doi:10.​1158/​1078-0432.​CCR-06-0369 PubMedCrossRef
14.
Zurück zum Zitat Petersen RP, Campa MJ, Sperlazza J, Conlon D, Joshi M-B, Harpole DH, Patz EF (2006) Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer 107:2866–2872. doi:10.1002/cncr.22282 PubMedCrossRef Petersen RP, Campa MJ, Sperlazza J, Conlon D, Joshi M-B, Harpole DH, Patz EF (2006) Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer 107:2866–2872. doi:10.​1002/​cncr.​22282 PubMedCrossRef
15.
Zurück zum Zitat Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu Y-X, Wang F-S (2007) Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 132:2328–2339. doi:10.1053/j.gastro.2007.03.102 PubMedCrossRef Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu Y-X, Wang F-S (2007) Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 132:2328–2339. doi:10.​1053/​j.​gastro.​2007.​03.​102 PubMedCrossRef
16.
Zurück zum Zitat Frey DM, Droeser RA, Viehl CT, Zlobec I, Lugli A, Zingg U, Oertli D, Kettelhack C, Terracciano L, Tornillo L (2010) High frequency of tumor-infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Int J Cancer 126:2635–2643. doi:10.1002/ijc.24989 PubMed Frey DM, Droeser RA, Viehl CT, Zlobec I, Lugli A, Zingg U, Oertli D, Kettelhack C, Terracciano L, Tornillo L (2010) High frequency of tumor-infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients. Int J Cancer 126:2635–2643. doi:10.​1002/​ijc.​24989 PubMed
17.
Zurück zum Zitat Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, Platell C, Iacopetta B (2009) Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27:186–192. doi:10.1200/JCO.2008.18.7229 PubMedCrossRef Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D, Platell C, Iacopetta B (2009) Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27:186–192. doi:10.​1200/​JCO.​2008.​18.​7229 PubMedCrossRef
18.
Zurück zum Zitat Blatner NR, Mulcahy MF, Dennis KL, Scholtens D, Bentrem DJ, Phillips JD, Ham S, Sandall BP, Khan MW, Mahvi DM, Halverson AL, Stryker SJ, Boller AM, Singal A, Sneed RK, Sarraj B, Ansari MJ, Oft M, Iwakura Y, Zhou L, Bonertz A, Beckhove P, Gounari F, Khazaie K (2012) Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer. Sci Transl Med 4:164ra159. doi:10.1126/scitranslmed.3004566 PubMedCentralPubMedCrossRef Blatner NR, Mulcahy MF, Dennis KL, Scholtens D, Bentrem DJ, Phillips JD, Ham S, Sandall BP, Khan MW, Mahvi DM, Halverson AL, Stryker SJ, Boller AM, Singal A, Sneed RK, Sarraj B, Ansari MJ, Oft M, Iwakura Y, Zhou L, Bonertz A, Beckhove P, Gounari F, Khazaie K (2012) Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancer. Sci Transl Med 4:164ra159. doi:10.​1126/​scitranslmed.​3004566 PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Ling KL, Pratap SE, Bates GJ, Singh B, Mortensen NJ, George BD, Warren BF, Piris J, Roncador G, Fox SB, Banham AH, Cerundolo V (2007) Increased frequency of regulatory T cells in peripheral blood and tumor infiltrating lymphocytes in colorectal cancer patients. Cancer Immun 7:7PubMedCentralPubMed Ling KL, Pratap SE, Bates GJ, Singh B, Mortensen NJ, George BD, Warren BF, Piris J, Roncador G, Fox SB, Banham AH, Cerundolo V (2007) Increased frequency of regulatory T cells in peripheral blood and tumor infiltrating lymphocytes in colorectal cancer patients. Cancer Immun 7:7PubMedCentralPubMed
20.
Zurück zum Zitat Le Gouvello S, Bastuji-Garin S, Aloulou N, Mansour H, Chaumette M-T, Berrehar F, Seikour A, Charachon A, Karoui M, Leroy K, Farcet J-P, Sobhani I (2008) High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut 57:772–779. doi:10.1136/gut.2007.123794 PubMedCrossRef Le Gouvello S, Bastuji-Garin S, Aloulou N, Mansour H, Chaumette M-T, Berrehar F, Seikour A, Charachon A, Karoui M, Leroy K, Farcet J-P, Sobhani I (2008) High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut 57:772–779. doi:10.​1136/​gut.​2007.​123794 PubMedCrossRef
21.
Zurück zum Zitat Michel S, Benner A, Tariverdian M, Wentzensen N, Hoefler P, Pommerencke T, Grabe N, von Knebel Doeberitz M, Kloor M (2008) High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability. Br J Cancer 99:1867–1873. doi:10.1038/sj.bjc.6604756 PubMedCentralPubMedCrossRef Michel S, Benner A, Tariverdian M, Wentzensen N, Hoefler P, Pommerencke T, Grabe N, von Knebel Doeberitz M, Kloor M (2008) High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability. Br J Cancer 99:1867–1873. doi:10.​1038/​sj.​bjc.​6604756 PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Lan F, Zhang L, Wu J, Zhang J, Zhang S, Li K, Qi Y, Lin P (2011) IL-23/IL-23R: potential mediator of intestinal tumor progression from adenomatous polyps to colorectal carcinoma. Int J Colorectal Dis 26:1511–1518. doi:10.1007/s00384-011-1232-6 PubMedCrossRef Lan F, Zhang L, Wu J, Zhang J, Zhang S, Li K, Qi Y, Lin P (2011) IL-23/IL-23R: potential mediator of intestinal tumor progression from adenomatous polyps to colorectal carcinoma. Int J Colorectal Dis 26:1511–1518. doi:10.​1007/​s00384-011-1232-6 PubMedCrossRef
26.
Zurück zum Zitat Moser AR, Pitot HC, Dove WF (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247:322–324PubMedCrossRef Moser AR, Pitot HC, Dove WF (1990) A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247:322–324PubMedCrossRef
29.
Zurück zum Zitat Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein N, Dove W (1993) Genetic identification of Mom-l, a major modifier locus affecting min-induced intestinal neoplasia in the mouse. Cell 75:631–639PubMedCrossRef Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein N, Dove W (1993) Genetic identification of Mom-l, a major modifier locus affecting min-induced intestinal neoplasia in the mouse. Cell 75:631–639PubMedCrossRef
37.
Zurück zum Zitat Lim HW, Lee J, Hillsamer P, Kim CH (2008) Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J Immunol 180:122–129PubMedCrossRef Lim HW, Lee J, Hillsamer P, Kim CH (2008) Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J Immunol 180:122–129PubMedCrossRef
40.
Zurück zum Zitat Hall AO, Beiting DP, Tato C, John B, Oldenhove G, Lombana CG, Pritchard GH, Silver JS, Bouladoux N, Stumhofer JS, Harris TH, Grainger J, Wojno EDT, Wagage S, Roos DS, Scott P, Turka LA, Cherry S, Reiner SL, Cua D, Belkaid Y, Elloso MM, Hunter CA (2012) The cytokines interleukin 27 and interferon-γ promote distinct treg cell populations required to limit infection-induced pathology. Immunity 37:511–523. doi:10.1016/j.immuni.2012.06.014 PubMedCentralPubMedCrossRef Hall AO, Beiting DP, Tato C, John B, Oldenhove G, Lombana CG, Pritchard GH, Silver JS, Bouladoux N, Stumhofer JS, Harris TH, Grainger J, Wojno EDT, Wagage S, Roos DS, Scott P, Turka LA, Cherry S, Reiner SL, Cua D, Belkaid Y, Elloso MM, Hunter CA (2012) The cytokines interleukin 27 and interferon-γ promote distinct treg cell populations required to limit infection-induced pathology. Immunity 37:511–523. doi:10.​1016/​j.​immuni.​2012.​06.​014 PubMedCentralPubMedCrossRef
41.
Zurück zum Zitat Redjimi N, Raffin C, Raimbaud I, Pignon P, Matsuzaki J, Odunsi K, Valmori D, Ayyoub M (2012) CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity. Cancer Res 72:4351–4360. doi:10.1158/0008-5472.CAN-12-0579 PubMedCrossRef Redjimi N, Raffin C, Raimbaud I, Pignon P, Matsuzaki J, Odunsi K, Valmori D, Ayyoub M (2012) CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity. Cancer Res 72:4351–4360. doi:10.​1158/​0008-5472.​CAN-12-0579 PubMedCrossRef
44.
Zurück zum Zitat Coletta PL (2004) Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesis. Blood 103:1050–1058PubMedCrossRef Coletta PL (2004) Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesis. Blood 103:1050–1058PubMedCrossRef
45.
46.
Zurück zum Zitat Dimberg J, Hugander A, Wågsäter D (2006) Protein expression of the chemokine, CCL28, in human colorectal cancer. Int J Oncol 28:315–319PubMed Dimberg J, Hugander A, Wågsäter D (2006) Protein expression of the chemokine, CCL28, in human colorectal cancer. Int J Oncol 28:315–319PubMed
47.
Zurück zum Zitat Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A, Bruneval P, Fridman WH, Becker C, Pagès F, Speicher MR, Trajanoski Z, Galon J (2013) Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39:782–795. doi:10.1016/j.immuni.2013.10.003 PubMedCrossRef Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A, Bruneval P, Fridman WH, Becker C, Pagès F, Speicher MR, Trajanoski Z, Galon J (2013) Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39:782–795. doi:10.​1016/​j.​immuni.​2013.​10.​003 PubMedCrossRef
48.
Zurück zum Zitat Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, Taniguchi K, Yu G-Y, Österreicher CH, Hung KE, Datz C, Feng Y, Fearon ER, Oukka M, Tessarollo L, Coppola V, Yarovinsky F, Cheroutre H, Eckmann L, Trinchieri G, Karin M (2012) Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumor growth. Nature 491:254–258. doi:10.1038/nature11465 PubMedCentralPubMed Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, Taniguchi K, Yu G-Y, Österreicher CH, Hung KE, Datz C, Feng Y, Fearon ER, Oukka M, Tessarollo L, Coppola V, Yarovinsky F, Cheroutre H, Eckmann L, Trinchieri G, Karin M (2012) Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumor growth. Nature 491:254–258. doi:10.​1038/​nature11465 PubMedCentralPubMed
51.
Zurück zum Zitat Ganesan AP, Johansson M, Ruffell B, Beltran A, Lau J, Jablons DM, Coussens LM (2013) Tumor-infiltrating regulatory t cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma. J Immunol 191:2009–2017. doi:10.4049/jimmunol.1301317 PubMedCrossRef Ganesan AP, Johansson M, Ruffell B, Beltran A, Lau J, Jablons DM, Coussens LM (2013) Tumor-infiltrating regulatory t cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma. J Immunol 191:2009–2017. doi:10.​4049/​jimmunol.​1301317 PubMedCrossRef
Metadaten
Titel
Altered chemokine production and accumulation of regulatory T cells in intestinal adenomas of APCMin/+ mice
verfasst von
Paulina Akeus
Veronica Langenes
Astrid von Mentzer
Ulf Yrlid
Åsa Sjöling
Pushpa Saksena
Sukanya Raghavan
Marianne Quiding-Järbrink
Publikationsdatum
01.08.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Cancer Immunology, Immunotherapy / Ausgabe 8/2014
Print ISSN: 0340-7004
Elektronische ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-014-1555-6

Weitere Artikel der Ausgabe 8/2014

Cancer Immunology, Immunotherapy 8/2014 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.